Cargando…
Bioactive nanotherapeutic trends to combat triple negative breast cancer
The management of aggressive breast cancer, particularly, triple negative breast cancer (TNBC) remains a formidable challenge, despite treatment advancement. Although newer therapies such as atezolizumab, olaparib, and sacituzumab can tackle the breast cancer prognosis and/or progression, but achiev...
Autores principales: | Chowdhury, Pallabita, Ghosh, Upasana, Samanta, Kamalika, Jaggi, Meena, Chauhan, Subhash C., Yallapu, Murali M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970221/ https://www.ncbi.nlm.nih.gov/pubmed/33778204 http://dx.doi.org/10.1016/j.bioactmat.2021.02.037 |
Ejemplares similares
-
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019) -
Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer
por: Chowdhury, Pallabita, et al.
Publicado: (2018) -
Tannic Acid-Lung Fluid Assemblies Promote Interaction and Delivery of Drugs to Lung Cancer Cells
por: Hatami, Elham, et al.
Publicado: (2018) -
Indocyanine Green-based Glow Nanoparticles Probe for Cancer Imaging
por: Chauhan, Neeraj, et al.
Publicado: (2023) -
Pectin-Tannic Acid Nano-Complexes Promote the Delivery and Bioactivity of Drugs in Pancreatic Cancer Cells
por: Chauhan, Sumeet S., et al.
Publicado: (2020)